Literature DB >> 2675784

Amyloidosis in the rheumatic diseases.

V Dhillon1, P Woo, D Isenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675784      PMCID: PMC1003851          DOI: 10.1136/ard.48.8.696

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  41 in total

1.  Dermatomyositis complicated by generalized amyloidosis. Report of a case.

Authors:  A H GELDERMAN; R A LEVINE; K A ARNDT
Journal:  N Engl J Med       Date:  1962-10-25       Impact factor: 91.245

2.  Amyloidosis in rheumatoid arthritis.

Authors:  G A MISSEN; J D TAYLOR
Journal:  J Pathol Bacteriol       Date:  1956-01

3.  Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.

Authors:  K Berglund; C Keller; H Thysell
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

4.  Epidemiologic survey of juvenile chronic arthritis in France. Comparison of data obtained from two different regions.

Authors:  A M Prieur; E Le Gall; F Karman; C Edan; O Lasserre; J Goujard
Journal:  Clin Exp Rheumatol       Date:  1987 Jul-Sep       Impact factor: 4.473

5.  Secondary amyloidosis affecting the skin in arthropathic psoriasis.

Authors:  S C Sharma; G Mortimer; S Kennedy; J Thomson
Journal:  Br J Dermatol       Date:  1983-02       Impact factor: 9.302

Review 6.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

7.  Scleroderma, amyloidosis, and extensor tendon rupture.

Authors:  H M Horwitz; J D DiBeneditto; S R Allegra; H M Baumann
Journal:  Arthritis Rheum       Date:  1982-09

8.  Presence and role of glycosaminoglycans in amyloidosis.

Authors:  A Linker; H C Carney
Journal:  Lab Invest       Date:  1987-09       Impact factor: 5.662

9.  Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component.

Authors:  P Woo; J R Korenberg; A S Whitehead
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

10.  Amyloid P-component is a constituent of normal human glomerular basement membrane.

Authors:  R F Dyck; C M Lockwood; M Kershaw; N McHugh; V C Duance; M L Baltz; M B Pepys
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Reactive amyloidosis.

Authors:  J David; P Woo
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

2.  Amyloidosis in rheumatic diseases.

Authors:  J Barash
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

3.  Adult onset Still's disease: clinical experience with 18 patients over 15 years in northern India.

Authors:  P Bambery; R J Thomas; H S Malhotra; U Kaur; S R Bhusnurmath; S D Deodhar
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

4.  Serum C-reactive protein is rarely lost into urine in patients with secondary amyloidosis and proteinuria.

Authors:  K Laiho; S Tiitinen; A M Teppo; M Kauppi; K Kaarela
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Ankylosing spondylitis and monoclonal gammopathies.

Authors:  G Renier; J C Renier; M Gardembas-Pain; A Chevailler; M Boasson; D Hurez
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

6.  Gout and AA-Amyloidosis: A Case-Based Review.

Authors:  Margarita Aleksandrovna Gromova; Vladimir Viktorovich Tsurko
Journal:  Mediterr J Rheumatol       Date:  2021-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.